Dose-Response Effect of Lesogaberan, a Novel γ-Aminobutyric Acid Type B (GABAB) Receptor Agonist, on Reflux Episodes in Patients With Gastroesophageal Reflux Disease With Symptoms Despite Proton Pump Inhibitor Treatment

Proton Pump Inhibitor ◽

Receptor Agonist ◽

Gabab Receptor ◽

Aminobutyric Acid ◽

Type B ◽

Acid Type ◽

Dose Response Effect ◽

Efficacy of a Novel γ-Aminobutyric Acid Type B Receptor (GABA B ) Agonist, Lesogaberan, as an Add-on to Proton Pump Inhibitor (PPI) Therapy in the Treatment of Gastroesophageal Reflux Disease in Patients Who Have a Partial Response to PPI Therapy

Gastroenterology ◽

10.1016/s0016-5085(11)62400-1 ◽

2011 ◽

Vol 140 (5) ◽

pp. S-580 ◽

Cited By ~ 4

Author(s):

Nicholas J. Shaheen ◽

Hans Denison ◽

Karin Björck ◽

Maria Karlsson ◽

Debra G. Silberg

Keyword(s):

Proton Pump Inhibitor ◽

Partial Response ◽

Gastroesophageal Reflux ◽

Proton Pump ◽

Reflux Disease ◽

Aminobutyric Acid ◽

Type B ◽

The gamma-aminobutyric acid type B (GABAB) receptor agonist baclofen inhibits morphine sensitization by decreasing the dopamine level in rat nucleus accumbens

Behavioral and Brain Functions ◽

10.1186/1744-9081-8-20 ◽

2012 ◽

Vol 8 (1) ◽

pp. 20 ◽

Cited By ~ 14

Author(s):

Zhenyu Fu ◽

Hongfa Yang ◽

Yuqiang Xiao ◽

Gang Zhao ◽

Haiyan Huang

Keyword(s):

Nucleus Accumbens ◽

Receptor Agonist ◽

Gabab Receptor ◽

Aminobutyric Acid ◽

Dopamine Level ◽

Gamma Aminobutyric Acid ◽

Type B ◽

Acid Type ◽

Rat Nucleus Accumbens

Safety Profile of a Novel γ-Aminobutyric Acid Type B Receptor (GABA B ) Agonist, Lesogaberan, as an Add-on to Proton Pump Inhibitor (PPI) Therapy in the Treatment of Gastroesophageal Reflux Disease in Patients Who Have a Partial Response to PPI Therapy

Gastroenterology ◽

10.1016/s0016-5085(11)62390-1 ◽

2011 ◽

Vol 140 (5) ◽

pp. S-577

Author(s):

Nicholas J. Shaheen ◽

Hans Denison ◽

Karin Björck ◽

Debra G. Silberg

Keyword(s):

Proton Pump Inhibitor ◽

Partial Response ◽

Gastroesophageal Reflux ◽

Proton Pump ◽

Reflux Disease ◽

Safety Profile ◽

Aminobutyric Acid ◽

Type B ◽

Synthesis and Pharmacological Evaluation of Novel γ-Aminobutyric Acid Type B (GABAB) Receptor Agonists as Gastroesophageal Reflux Inhibitors

Journal of Medicinal Chemistry ◽

10.1021/jm701425k ◽

2008 ◽

Vol 51 (14) ◽

pp. 4315-4320 ◽

Cited By ~ 32

Author(s):

Christer Alstermark ◽

Kosrat Amin ◽

Sean R. Dinn ◽

Thomas Elebring ◽

Ola Fjellström ◽

...

Keyword(s):

Gastroesophageal Reflux ◽

Gabab Receptor ◽

Aminobutyric Acid ◽

Type B ◽

Receptor Agonists ◽

Pharmacological Evaluation ◽

The Relationship Between Type 2 Diabetes Mellitus and Failure to Proton Pump Inhibitor Treatment in Gastroesophageal Reflux Disease

Journal of Clinical Gastroenterology ◽

10.1097/mcg.0b013e31824e139b ◽

2012 ◽

Vol 46 (8) ◽

pp. 662-668 ◽

Cited By ~ 15

Author(s):

Tiberiu Hershcovici ◽

Lokesh K. Jha ◽

Rakshith Gadam ◽

Haiyan Cui ◽

Lauren Gerson ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Proton Pump Inhibitor ◽

Gastroesophageal Reflux ◽

The Relationship ◽

Evaluation of Difluoromethyl Ketones as Agonists of the γ-Aminobutyric Acid Type B (GABAB) Receptor

Journal of Medicinal Chemistry ◽

10.1021/jm301805e ◽

2013 ◽

Vol 56 (6) ◽

pp. 2456-2465 ◽

Cited By ~ 55

Author(s):

Changho Han ◽

Amy E. Salyer ◽

Eun Hoo Kim ◽

Xinyi Jiang ◽

Rachel E. Jarrard ◽

...

Keyword(s):

Gabab Receptor ◽

Aminobutyric Acid ◽

Type B ◽

Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial

BMC Gastroenterology ◽

10.1186/1471-230x-13-145 ◽

2013 ◽

Vol 13 (1) ◽

Cited By ~ 5

Author(s):

Hubert Mönnikes ◽

Thomas Schwan ◽

Christo van Rensburg ◽

Andrzej Straszak ◽

Carmen Theek ◽

...

Keyword(s):

Quality Of Life ◽

Randomized Controlled Trial ◽

Proton Pump Inhibitor ◽

Controlled Trial ◽

Randomized Controlled ◽

Prospective Randomized Controlled Trial ◽

The Therapeutic and Diagnostic Value of 2-week High Dose Proton Pump Inhibitor Treatment in Overlapping Non-erosive Gastroesophageal Reflux Disease and Functional Dyspepsia Patients

Journal of Neurogastroenterology and Motility ◽

10.5056/jnm.2012.18.2.174 ◽

2012 ◽

Vol 18 (2) ◽

pp. 174-180 ◽

Cited By ~ 8

Author(s):

Chatchai Kriengkirakul ◽

Tanisa Patcharatrakul ◽

Sutep Gonlachanvit

Keyword(s):

Proton Pump Inhibitor ◽

Gastroesophageal Reflux ◽

Functional Dyspepsia ◽

Proton Pump ◽

Reflux Disease ◽

Diagnostic Value ◽

High Dose ◽

Respiratory response to proton pump inhibitor treatment in children with obstructive sleep apnea syndrome and gastroesophageal reflux disease

Sleep Medicine ◽

10.1016/j.sleep.2012.04.016 ◽

2012 ◽

Vol 13 (7) ◽

pp. 824-830 ◽

Cited By ~ 18

Author(s):

Jolanta Wasilewska ◽

Janusz Semeniuk ◽

Beata Cudowska ◽

Mark Klukowski ◽

Katarzyna Dębkowska ◽

...

Keyword(s):

Obstructive Sleep Apnea ◽

Sleep Apnea ◽

Proton Pump Inhibitor ◽

Sleep Apnea Syndrome ◽

Respiratory Response ◽

Obstructive Sleep ◽

Apnea Syndrome ◽

PGS7 COST ANALYSIS OF A NEW PROPOSAL FOR REIMBURSEMENT OF PROTON PUMP INHIBITOR TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD) IN BELGIUM

Value in Health ◽

10.1016/s1098-3015(10)61752-4 ◽

2003 ◽

Vol 6 (6) ◽

pp. 685-686

Author(s):

PB Van Wilder ◽

F Arickx ◽

C Vannecke ◽

M Hiele ◽

GA Verpooten

Keyword(s):

Proton Pump Inhibitor ◽

Gastroesophageal Reflux ◽

Cost Analysis ◽

Proton Pump ◽

Reflux Disease ◽